Titre : Facteur de croissance transformant bêta-1

Facteur de croissance transformant bêta-1 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Pilot Projects
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Facteur de croissance transformant bêta-1 : Questions médicales les plus fréquentes", "headline": "Facteur de croissance transformant bêta-1 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Facteur de croissance transformant bêta-1 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-12", "dateModified": "2025-05-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Facteur de croissance transformant bêta-1" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Facteur de croissance transformant bêta", "url": "https://questionsmedicales.fr/mesh/D016212", "about": { "@type": "MedicalCondition", "name": "Facteur de croissance transformant bêta", "code": { "@type": "MedicalCode", "code": "D016212", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529.942.775" } } }, "about": { "@type": "MedicalCondition", "name": "Facteur de croissance transformant bêta-1", "alternateName": "Transforming Growth Factor beta1", "code": { "@type": "MedicalCode", "code": "D053773", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Juan F Santibanez", "url": "https://questionsmedicales.fr/author/Juan%20F%20Santibanez", "affiliation": { "@type": "Organization", "name": "Molecular oncology group, Institute for Medical Research, University of Belgrade, Republic of Serbia." } }, { "@type": "Person", "name": "Xin Fang", "url": "https://questionsmedicales.fr/author/Xin%20Fang", "affiliation": { "@type": "Organization", "name": "Department of Medical Ultrasound, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China." } }, { "@type": "Person", "name": "Shotaro Takano", "url": "https://questionsmedicales.fr/author/Shotaro%20Takano", "affiliation": { "@type": "Organization", "name": "Department of Orthopedic Surgery, Kitasato University School of Medicine, 1-15-1 Minami-ku, Kitasato, Sagamihara City, Kanagawa 252-0374, Japan." } }, { "@type": "Person", "name": "Kentaro Uchida", "url": "https://questionsmedicales.fr/author/Kentaro%20Uchida", "affiliation": { "@type": "Organization", "name": "Department of Orthopedic Surgery, Kitasato University School of Medicine, 1-15-1 Minami-ku, Kitasato, Sagamihara City, Kanagawa 252-0374, Japan." } }, { "@type": "Person", "name": "Makoto Itakura", "url": "https://questionsmedicales.fr/author/Makoto%20Itakura", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry, Kitasato University School of Medicine, 1-15-1 Minami-ku, Kitasato, Sagamihara City, Kanagawa 252-0374, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "SARS-CoV-2 rapid antigen screening of asymptomatic employees: a pilot project.", "datePublished": "2022-09-12", "url": "https://questionsmedicales.fr/article/36097245", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.17269/s41997-022-00691-z" } }, { "@type": "ScholarlyArticle", "name": "Health Disparities Investigator Development through a Team-Science Pilot Projects Program.", "datePublished": "2023-03-30", "url": "https://questionsmedicales.fr/article/37047951", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph20075336" } }, { "@type": "ScholarlyArticle", "name": "Global pen pal education intervention among student pharmacists: A pilot project.", "datePublished": "2022-09-22", "url": "https://questionsmedicales.fr/article/36153244", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cptl.2022.09.020" } }, { "@type": "ScholarlyArticle", "name": "A Disposable Diaper Collection Project in Langa, Cape Town, South Africa: A Pilot Study.", "datePublished": "2024-09-27", "url": "https://questionsmedicales.fr/article/39457265", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph21101292" } }, { "@type": "ScholarlyArticle", "name": "Changing the Playing Field: A Prehospital Blood Product Pilot Project in Rural North Georgia.", "datePublished": "2023-02-16", "url": "https://questionsmedicales.fr/article/36798046", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/00031348231157833" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Facteurs biologiques", "item": "https://questionsmedicales.fr/mesh/D001685" }, { "@type": "ListItem", "position": 3, "name": "Protéines et peptides de signalisation intercellulaire", "item": "https://questionsmedicales.fr/mesh/D036341" }, { "@type": "ListItem", "position": 4, "name": "Protéines de la superfamille du TGF bêta", "item": "https://questionsmedicales.fr/mesh/D055411" }, { "@type": "ListItem", "position": 5, "name": "Facteur de croissance transformant bêta", "item": "https://questionsmedicales.fr/mesh/D016212" }, { "@type": "ListItem", "position": 6, "name": "Facteur de croissance transformant bêta-1", "item": "https://questionsmedicales.fr/mesh/D053773" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Facteur de croissance transformant bêta-1 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Facteur de croissance transformant bêta-1", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Facteur de croissance transformant bêta-1", "description": "Comment diagnostiquer une anomalie de TGF-β1 ?\nQuels tests sont utilisés pour évaluer TGF-β1 ?\nLe TGF-β1 est-il lié à des maladies spécifiques ?\nQuels biomarqueurs sont associés à TGF-β1 ?\nPeut-on détecter TGF-β1 dans les tissus ?", "url": "https://questionsmedicales.fr/mesh/D053773?mesh_terms=Pilot+Projects&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Facteur de croissance transformant bêta-1", "description": "Quels symptômes sont liés à un excès de TGF-β1 ?\nLe TGF-β1 affecte-t-il le système immunitaire ?\nQuels signes cliniques indiquent une dysrégulation de TGF-β1 ?\nLe TGF-β1 est-il impliqué dans des douleurs chroniques ?\nY a-t-il des symptômes neurologiques associés à TGF-β1 ?", "url": "https://questionsmedicales.fr/mesh/D053773?mesh_terms=Pilot+Projects&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Facteur de croissance transformant bêta-1", "description": "Comment prévenir les déséquilibres de TGF-β1 ?\nY a-t-il des habitudes à éviter pour TGF-β1 ?\nLe stress influence-t-il TGF-β1 ?\nDes exercices réguliers aident-ils TGF-β1 ?\nLes suppléments alimentaires affectent-ils TGF-β1 ?", "url": "https://questionsmedicales.fr/mesh/D053773?mesh_terms=Pilot+Projects&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Facteur de croissance transformant bêta-1", "description": "Comment traiter un excès de TGF-β1 ?\nLe TGF-β1 peut-il être ciblé dans le cancer ?\nQuels médicaments influencent TGF-β1 ?\nY a-t-il des traitements naturels pour TGF-β1 ?\nLes thérapies géniques peuvent-elles cibler TGF-β1 ?", "url": "https://questionsmedicales.fr/mesh/D053773?mesh_terms=Pilot+Projects&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Facteur de croissance transformant bêta-1", "description": "Quelles complications sont liées à un excès de TGF-β1 ?\nLe TGF-β1 est-il impliqué dans des maladies auto-immunes ?\nComment TGF-β1 affecte-t-il la cicatrisation ?\nLe TGF-β1 est-il lié à des maladies cardiovasculaires ?\nDes troubles respiratoires peuvent-ils être causés par TGF-β1 ?", "url": "https://questionsmedicales.fr/mesh/D053773?mesh_terms=Pilot+Projects&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Facteur de croissance transformant bêta-1", "description": "Quels facteurs augmentent le TGF-β1 ?\nL'âge influence-t-il les niveaux de TGF-β1 ?\nLes infections peuvent-elles affecter TGF-β1 ?\nLe mode de vie sédentaire influence-t-il TGF-β1 ?\nY a-t-il un lien entre l'alimentation et TGF-β1 ?", "url": "https://questionsmedicales.fr/mesh/D053773?mesh_terms=Pilot+Projects&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anomalie de TGF-β1 ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins mesurant les niveaux de TGF-β1 peuvent être effectués." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer TGF-β1 ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les dosages ELISA et les tests immunohistochimiques sont courants." } }, { "@type": "Question", "name": "Le TGF-β1 est-il lié à des maladies spécifiques ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est associé à des maladies comme la fibrose et certains cancers." } }, { "@type": "Question", "name": "Quels biomarqueurs sont associés à TGF-β1 ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des biomarqueurs comme le collagène et les cytokines pro-inflammatoires peuvent être mesurés." } }, { "@type": "Question", "name": "Peut-on détecter TGF-β1 dans les tissus ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'immunohistochimie permet de visualiser TGF-β1 dans les tissus." } }, { "@type": "Question", "name": "Quels symptômes sont liés à un excès de TGF-β1 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Un excès peut entraîner fibrose, inflammation et troubles immunitaires." } }, { "@type": "Question", "name": "Le TGF-β1 affecte-t-il le système immunitaire ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il régule la réponse immunitaire et peut induire une immunosuppression." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une dysrégulation de TGF-β1 ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme la fibrose pulmonaire ou des lésions cutanées peuvent apparaître." } }, { "@type": "Question", "name": "Le TGF-β1 est-il impliqué dans des douleurs chroniques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut contribuer à des douleurs chroniques par son rôle dans l'inflammation." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques associés à TGF-β1 ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un lien entre TGF-β1 et des troubles neurologiques." } }, { "@type": "Question", "name": "Comment prévenir les déséquilibres de TGF-β1 ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain et une alimentation équilibrée peuvent aider." } }, { "@type": "Question", "name": "Y a-t-il des habitudes à éviter pour TGF-β1 ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabagisme et l'exposition à des toxines peut réduire les risques." } }, { "@type": "Question", "name": "Le stress influence-t-il TGF-β1 ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut augmenter les niveaux de TGF-β1." } }, { "@type": "Question", "name": "Des exercices réguliers aident-ils TGF-β1 ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice modéré peut réguler les niveaux de TGF-β1." } }, { "@type": "Question", "name": "Les suppléments alimentaires affectent-ils TGF-β1 ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certains suppléments, comme les oméga-3, peuvent moduler TGF-β1." } }, { "@type": "Question", "name": "Comment traiter un excès de TGF-β1 ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des inhibiteurs de TGF-β1 et des thérapies ciblées peuvent être utilisés." } }, { "@type": "Question", "name": "Le TGF-β1 peut-il être ciblé dans le cancer ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des thérapies anti-TGF-β1 sont en développement pour certains cancers." } }, { "@type": "Question", "name": "Quels médicaments influencent TGF-β1 ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme les corticostéroïdes peuvent moduler son activité." } }, { "@type": "Question", "name": "Y a-t-il des traitements naturels pour TGF-β1 ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certaines plantes médicinales peuvent avoir un effet modulateur sur TGF-β1." } }, { "@type": "Question", "name": "Les thérapies géniques peuvent-elles cibler TGF-β1 ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie génique est explorée pour réguler l'expression de TGF-β1." } }, { "@type": "Question", "name": "Quelles complications sont liées à un excès de TGF-β1 ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme la fibrose, l'hypertension pulmonaire et le cancer peuvent survenir." } }, { "@type": "Question", "name": "Le TGF-β1 est-il impliqué dans des maladies auto-immunes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut jouer un rôle dans la pathogenèse de certaines maladies auto-immunes." } }, { "@type": "Question", "name": "Comment TGF-β1 affecte-t-il la cicatrisation ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Un excès de TGF-β1 peut entraîner une cicatrisation excessive et des cicatrices hypertrophiques." } }, { "@type": "Question", "name": "Le TGF-β1 est-il lié à des maladies cardiovasculaires ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux élevés de TGF-β1 sont associés à un risque accru de maladies cardiovasculaires." } }, { "@type": "Question", "name": "Des troubles respiratoires peuvent-ils être causés par TGF-β1 ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, TGF-β1 est impliqué dans des troubles comme la fibrose pulmonaire." } }, { "@type": "Question", "name": "Quels facteurs augmentent le TGF-β1 ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'inflammation chronique, le tabagisme et l'obésité sont des facteurs de risque." } }, { "@type": "Question", "name": "L'âge influence-t-il les niveaux de TGF-β1 ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les niveaux de TGF-β1 augmentent souvent avec l'âge." } }, { "@type": "Question", "name": "Les infections peuvent-elles affecter TGF-β1 ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections peuvent induire une augmentation de TGF-β1." } }, { "@type": "Question", "name": "Le mode de vie sédentaire influence-t-il TGF-β1 ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire peut contribuer à des niveaux élevés de TGF-β1." } }, { "@type": "Question", "name": "Y a-t-il un lien entre l'alimentation et TGF-β1 ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en graisses saturées peut augmenter TGF-β1." } } ] } ] }

Sources (10000 au total)

SARS-CoV-2 rapid antigen screening of asymptomatic employees: a pilot project.

Rapid antigen screening can be effective in identifying infectious individuals in occupational settings to reduce transmission and outbreaks. We report results from a pilot project at the Greater Toro... An employee screening program was piloted between March 8 and May 28, 2021, to implement rapid antigen testing for asymptomatic employees. Recruitment targeted enrolment of 400 employees and yielded p... A total of 5117 tests were performed on 717 individuals over 12 weeks; 5091 tests were negative (99.5%), and 22 individuals tested positive (3.1% positivity rate). One hundred twenty-four (17%) comple... This pilot program identified 22 (3.1%) potentially infectious employees. Onsite testing was feasible and highly accepted by this group of employees who completed the survey. Education resulted in rea...

Global pen pal education intervention among student pharmacists: A pilot project.

Global health, a practice that prioritizes improving health and achieving health equity for all people worldwide, is a priority for pharmacists, schools, and pharmacy colleges. Several initiatives aim... This mixed-method study included assigned engagement within a required or elective didactic course, followed by a post-experience survey. Each student was pre-assigned a pen pal from a cohort of pharm... In total, 184 students completed the learning experience, and across both sites, 63 students completed the post-experience survey. The students' impressions of the PPP varied by site, yet most partici...

Changing the Playing Field: A Prehospital Blood Product Pilot Project in Rural North Georgia.

In Georgia, the paramedic's scope of practice prohibited the initiation of blood products. Due to the rural landscape in Georgia, one region's Regional Trauma Advisory Committee (RTAC) advocated expan... Approval was obtained from the state medical directors and the Office of EMS and Trauma. The project team addressed product selection, equipment, prehospital service selection, education, policies and... The pilot project began in spring of 2020, and as of January 2023, there have been 100 field initiations and no adverse effects, demonstrating the safety of paramedics to initiate blood products in th...

Community-supported teaching on the topic of transgender identity in undergraduate medical education - a pilot project.

Future physicians are insufficiently prepared for the topic of transgender identity during their studies. Relevant courses during undergraduate medical education are heterogeneous and not widely estab... During summer semester 2021 (SS21), the knowledge level on transgender identity of 134 medical students in their fifth clinical semester was evaluated (phase 1). In addition, knowledge gain on gender ... The students in SS21 did not feel sufficiently educated in the topic of transgender identity through their studies, but rated the relevance of the topic for their later profession as high. Learning ga... One 90-minutes seminar led to a significant learning gain regarding the topic of transgender identity. Community-supported teaching is a promising way to impart knowledge in a qualified manner: Medica...

Assessing tenant health amid social housing redevelopment: lessons from a pilot project.

To trial methods for a future longitudinal study to: a) assess how the redevelopment of a large social housing estate affects the health of tenants; and b) act on health needs identified throughout th... Participants recruited from the tenant population completed (online or face-to-face) a health questionnaire covering self-reported health status and behaviours, housing conditions, sense of community,... A total of 24 tenants were recruited for the pilot study against a target sample size of 50. The health questionnaire and referral process worked as expected, with no issues reported.... This pilot study successfully trialled methods for: a) assessing tenants' health; and b) referring those identified as being likely to have unmet health service needs to a community-based link worker,...

Developing a trigger tool to monitor adverse events during haemodialysis in children: a pilot project.

We developed a paediatric haemodialysis trigger tool (pHTT) for application per haemodialysis (HD) session in children receiving intermittent in-centre HD and systematically monitored adverse events.... Single-centre quality improvement study performed over two 8-week cycles. Data collected prospectively using a 'per-dialysis session' pHTT tool including 54 triggers across six domains, adapted from a... There were 241 triggers over 182 dialysis sessions, with 139 triggers in 91 HD sessions for 15 children, age range 28-205 months, over an 8-week period (first cycle) and 102 triggers in 91 HD sessions... This pilot study demonstrates potential benefits of a bedside tool to monitor adverse events during haemodialysis in children. Thus, following interventions informed by the pHTT, the harm rate per ses...

vSEMERA: pilot project assessing health profession students' experiences in an international virtual research program.

The "Virtual Semester for Medical Research Aachen" (vSEMERA) is an international, interdisciplinary, virtual education program developed for health profession students. The first edition (2021) was ho... vSEMERA was built on a virtual learning platform, the "vSEMERA-Campus", designed to foster students' learning process and social interactions. Maximum flexibility was offered through synchronous and a... The program received a rating of 4.38 out of 5 stars. While it met most expectations (4.29 out of 5), participants were unable to attend as many courses as intended (2.81 out of 5), mainly due to sche... vSEMERA represents a promising example of an online international learning and exchange program using pedagogical and technological elements of virtual collaboration and teaching. In addition to advan...